Cargando…
Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma
Immune suppression by CD4(+)FOXP3(+) regulatory T (Treg) cells and tumor infiltration by CD8(+) effector T cells represent two major factors impacting response to cancer immunotherapy. Using deconvolution-based transcriptional profiling of human papilloma virus (HPV)-negative oral squamous cell carc...
Autores principales: | Chao, Jaime L., Korzinkin, Michael, Zhavoronkov, Alex, Ozerov, Ivan V., Walker, Matthew T., Higgins, Kathleen, Lingen, Mark W., Izumchenko, Evgeny, Savage, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484691/ https://www.ncbi.nlm.nih.gov/pubmed/34622236 http://dx.doi.org/10.1016/j.xcrm.2021.100399 |
Ejemplares similares
-
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma
por: Broner, Esther C., et al.
Publicado: (2021) -
Loss of TET2 and TET3 in regulatory T cells unleashes effector function
por: Yue, Xiaojing, et al.
Publicado: (2019) -
In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia
por: Makarev, Eugene, et al.
Publicado: (2017) -
Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity
por: Kalim, Khalid W, et al.
Publicado: (2022) -
High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
por: Mkrtchyan, Garik V., et al.
Publicado: (2022)